Clinical trials
Enrolling by invitation trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 11 |
| 2024 | 10 |
| 2025 | 15 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 6 |
| Sanofi | 4 |
| Biogen | 2 |
| Pharvaris Netherlands B.V. | 2 |
| The University of Texas Health Science Center, Houston | 2 |
| UCB Biopharma SRL | 2 |
| AbbVie | 1 |
| Agios Pharmaceuticals, Inc. | 1 |
| AstraZeneca | 1 |
| Astria Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Angioedemas, Hereditary | 3 |
| Asthma | 2 |
| Breast Neoplasms | 2 |
| Dermatomyositis | 2 |
| Epilepsy | 2 |
| Hemophilia A | 2 |
| Hemophilia B | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Neoplasms | 2 |
| Respiratory Distress Syndrome | 2 |
Trials
Showing 51 to 51 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.